Добро пожаловать
Зарегистрировать аккаунт
Войдите, используя email
Зарегистрируйтесь с помощью email
Проверь свои входящие
Azenta Life Sciences
About
Azenta is a provider of life sciences solutions worldwide, enabling impactful breakthroughs and therapies to market faster.
- 1001 - 5000
Details
- Last Funding Type
- Post-IPO Equity
- Last Funding Money Raised
- $500M
- Industries
- Biopharma,Biotechnology,Life Science
- Founded date
- Jan 1, 1978
- Number Of Employee
- 1001 - 5000
- Operating Status
- Active
BioCision’s mission is to standardize pre-analytical sample handling. They develop novel products that eliminate variability in common, often-overlooked, laboratory procedures. Their products are marketed globally and are widely used by the leading institutions in the biotech, pharmaceutical, clinical, diagnostic, academic and government scientific community. BioCision’s products include CoolRack®, CoolSink™ and ThermalTray™ laboratory tube and plate temperature standardizing modules, CoolBox™ ice-free benchtop coolers, CoolCell® alcohol-free cell freezing containers and TruCool™ accessories and consumables.
Funding Rounds
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Nov 23, 2022 | Post-IPO Equity | $500M | 1 |
JP Morgan Chase
|
— | Detail |
Investors
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
JP Morgan Chase
|
Yes | Post-IPO Equity |
